SCHEMBL9869306

SCHEMBL9869306

Cc1cccc(-c2nsc(S(N)(=O)=O)n2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.49
NPC1 O15118 2/20 0.45
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
ALDH1A1 P00352 7/20 0.44
LMNA P02545 3/20 0.44
MAPT P10636 2/20 0.44
HSD17B10 Q99714 5/20 0.44
HPGD P15428 4/20 0.44
TP53 P04637 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
FAAH O00519 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CA5A P35218 1/20 0.40
CA5B Q9Y2D0 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9868393 0.82 HSD17B1 (0.60) CA1CA2MAPTCYP1A2CYP2C9
SCHEMBL9867251 0.82 CA1 (0.45) RAB9ANPC1CA1CA2ALDH1A1
SCHEMBL9867042 0.81 CYP19A1 (0.54) RAB9ANPC1CA1CA2ALDH1A1
SCHEMBL9866053 0.81 CA2 (0.43) CA1CA2ALDH1A1MAPTHSD17B10
SCHEMBL9867067 0.80 ADORA3 (0.56) RAB9ANPC1CA1CA2LMNA
SCHEMBL12266901 0.77 RAB9A (0.53) RAB9ANPC1ALDH1A1LMNAMAPT
SCHEMBL7513504 0.75 FAAH (0.42) ALDH1A1LMNAMAPTHPGDSMN1; SMN2
SCHEMBL23042515 0.74 RAB9A (0.50) RAB9ANPC1ALDH1A1LMNAMAPT
SCHEMBL14755837 0.74 ALDH1A1 (0.51) RAB9ANPC1ALDH1A1LMNAMAPT
SCHEMBL9867907 0.74 ALDH1A1 (0.54) RAB9ANPC1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4985450-A TREATMENT OF GLAUCOMA AVENTIS PHARMACEUTICALS INC. 1991-01-15 US disclosed
US-4873239-A GLAUCOMA TREATMENT HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-10-10 US disclosed
EP-0276822-A1 Arylthiadiazolylsulfonamides and derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-08-03 EP disclosed
US-4758578-A Arylthiadiazolylsulfonamides, pharmaceutical compositions and use HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) 1988-07-19 US disclosed